# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001837607-25-000055
Filing Date
2025-05-20
Accepted
2025-05-20 16:04:52
Documents
28
Period of Report
2025-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aeon-20250520x8k.htm iXBRL | 8-K | 42215
2 | EX-99 | aeon-20250520xex99.htm | EX-99 | 29452
3 | GRAPHIC | aeon-20250520xex99g001.jpg | GRAPHIC | 72502
4 | GRAPHIC | aeon-20250520xex99g002.jpg | GRAPHIC | 351534
5 | GRAPHIC | aeon-20250520xex99g003.jpg | GRAPHIC | 140030
6 | GRAPHIC | aeon-20250520xex99g004.jpg | GRAPHIC | 159376
7 | GRAPHIC | aeon-20250520xex99g005.jpg | GRAPHIC | 181547
8 | GRAPHIC | aeon-20250520xex99g006.jpg | GRAPHIC | 160649
9 | GRAPHIC | aeon-20250520xex99g007.jpg | GRAPHIC | 166987
10 | GRAPHIC | aeon-20250520xex99g008.jpg | GRAPHIC | 173636
11 | GRAPHIC | aeon-20250520xex99g009.jpg | GRAPHIC | 132891
12 | GRAPHIC | aeon-20250520xex99g010.jpg | GRAPHIC | 124590
13 | GRAPHIC | aeon-20250520xex99g011.jpg | GRAPHIC | 153007
14 | GRAPHIC | aeon-20250520xex99g012.jpg | GRAPHIC | 128247
15 | GRAPHIC | aeon-20250520xex99g013.jpg | GRAPHIC | 121997
16 | GRAPHIC | aeon-20250520xex99g014.jpg | GRAPHIC | 149492
| Complete submission text file | 0001837607-25-000055.txt |  | 3255239

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | EX-101.SCH | aeon-20250520.xsd | EX-101.SCH | 4152
18 | EX-101.DEF | aeon-20250520_def.xml | EX-101.DEF | 2869
19 | EX-101.LAB | aeon-20250520_lab.xml | EX-101.LAB | 17853
20 | EX-101.PRE | aeon-20250520_pre.xml | EX-101.PRE | 10675
30 | EXTRACTED XBRL INSTANCE DOCUMENT | aeon-20250520x8k_htm.xml | XML | 5053

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 25968663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)